Literature DB >> 25595736

Critical role of CD4 T cells in PF4/heparin antibody production in mice.

Yongwei Zheng1, Mei Yu2, Anand Padmanabhan2, Richard H Aster2, Liudi Yuan3, Renren Wen2, Demin Wang2.   

Abstract

Antibodies specific for platelet factor 4 (PF4)/heparin complexes are central to the pathogenesis of heparin-induced thrombocytopenia. Marginal zone B cells appear to be the source of such antibodies, but whether T-cell help is required is unclear. Here, we showed that induction of PF4/heparin-specific antibodies by PF4/heparin complexes was markedly impaired in mice depleted of CD4 T cells by anti-CD4 antibodies. Furthermore, Rag1-deficient recipient mice produced PF4/heparin-specific antibodies upon PF4/heparin challenge when reconstituted with a mixture of wild-type splenic B cells and splenocytes from B-cell-deficient (μMT) mice but not splenocytes from T- and B-cell-deficient (Rag1 knockout) mice. Lastly, mice with B cells lacking CD40, a B-cell costimulatory molecule that helps T-cell-dependent B-cell responses, displayed a marked reduction of PF4/heparin-specific antibody production following PF4/heparin challenge. Together, these findings show that helper T cells play a critical role in production of PF4/heparin-specific antibodies.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25595736      PMCID: PMC4357587          DOI: 10.1182/blood-2014-09-603464

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

1.  B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals.

Authors:  F Loder; B Mutschler; R J Ray; C J Paige; P Sideras; R Torres; M C Lamers; R Carsetti
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

2.  CD4+ T cells and CD40 participate in selection and homeostasis of peripheral B cells.

Authors:  Marc A Schwartz; Nikita S Kolhatkar; Chris Thouvenel; Socheath Khim; David J Rawlings
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

3.  The ability of B cells to participate in allogeneic cognate T-B cell interactions in vitro depends on the presence of CD4+ T cells during their development.

Authors:  M González; R Merino; A L González; J Merino
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

4.  Complexes of heparin and platelet factor 4 specifically stimulate T cells from patients with heparin-induced thrombocytopenia/thrombosis.

Authors:  S Bacsi; R De Palma; G P Visentin; J Gorski; R H Aster
Journal:  Blood       Date:  1999-07-01       Impact factor: 22.113

5.  PF4/heparin complexes are T cell-dependent antigens.

Authors:  Shayela Suvarna; Lubica Rauova; Emily K E McCracken; Christina M Goss; Bruce S Sachais; Steven E McKenzie; Michael P Reilly; Michael Dee Gunn; Douglas B Cines; Mortimer Poncz; Gowthami Arepally
Journal:  Blood       Date:  2005-04-21       Impact factor: 22.113

6.  Characterization of the humoral immune response in heparin-induced thrombocytopenia.

Authors:  J S Suh; M I Malik; R H Aster; G P Visentin
Journal:  Am J Hematol       Date:  1997-03       Impact factor: 10.047

7.  Humoral immune responses in CD40 ligand-deficient mice.

Authors:  B R Renshaw; W C Fanslow; R J Armitage; K A Campbell; D Liggitt; B Wright; B L Davison; C R Maliszewski
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

8.  Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen.

Authors:  Haifeng Song; Jan Cerny
Journal:  J Exp Med       Date:  2003-12-08       Impact factor: 14.307

9.  Critical role for mouse marginal zone B cells in PF4/heparin antibody production.

Authors:  Yongwei Zheng; Mei Yu; Andrew Podd; Liudi Yuan; Debra K Newman; Renren Wen; Gowthami Arepally; Demin Wang
Journal:  Blood       Date:  2013-03-04       Impact factor: 22.113

10.  The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation.

Authors:  T Kawabe; T Naka; K Yoshida; T Tanaka; H Fujiwara; S Suematsu; N Yoshida; T Kishimoto; H Kikutani
Journal:  Immunity       Date:  1994-06       Impact factor: 31.745

View more
  12 in total

1.  What's new about heparin-induced thrombocytopenia type II.

Authors:  Yasser Sakr
Journal:  Intensive Care Med       Date:  2015-04-23       Impact factor: 17.440

2.  Association between the HLA-DRB1*03:01-DQB1*02:01 haplotype and PF4/heparin antibodies.

Authors:  Ray Zhang; Brian F Duffy; Vinzenz Lange; Charles S Eby; Chang Liu
Journal:  Blood Adv       Date:  2019-10-22

Review 3.  Immune pathogenesis of heparin-induced thrombocytopenia.

Authors:  Sanjay Khandelwal; Gowthami M Arepally
Journal:  Thromb Haemost       Date:  2016-07-28       Impact factor: 5.249

4.  Regulatory T Cells Control PF4/Heparin Antibody Production in Mice.

Authors:  Yongwei Zheng; Wen Zhu; Dipica Haribhai; Calvin B Williams; Richard H Aster; Renren Wen; Demin Wang
Journal:  J Immunol       Date:  2019-08-30       Impact factor: 5.422

5.  A Case of Heparin-Induced Thrombocytopenia That Developed in the Therapeutic Course of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.

Authors:  Taketoshi Nonaka; Makoto Harada; Masahiko Sumi; Wataru Ishii; Tohru Ichikawa; Mamoru Kobayashi
Journal:  Case Rep Rheumatol       Date:  2019-07-22

6.  Dopaminergic stimulation leads B-cell infiltration into the central nervous system upon autoimmunity.

Authors:  Carolina Prado; Francisco Osorio-Barrios; Paulina Falcón; Alexandra Espinoza; Juan José Saez; María Isabel Yuseff; Rodrigo Pacheco
Journal:  J Neuroinflammation       Date:  2021-12-17       Impact factor: 8.322

7.  COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis.

Authors:  Clio Bilotta; Giulio Perrone; Valeria Adelfio; Giovanni Francesco Spatola; Maria Laura Uzzo; Antonina Argo; Stefania Zerbo
Journal:  Front Immunol       Date:  2021-11-29       Impact factor: 7.561

8.  Polyreactive IgM initiates complement activation by PF4/heparin complexes through the classical pathway.

Authors:  Sanjay Khandelwal; Joann Ravi; Lubica Rauova; Alexandra Johnson; Grace M Lee; Jennifer B Gilner; Sreenivasulu Gunti; Abner L Notkins; Maragatha Kuchibhatla; Michael Frank; Mortimer Poncz; Douglas B Cines; Gowthami M Arepally
Journal:  Blood       Date:  2018-10-11       Impact factor: 25.476

9.  Temporality of heparin-induced antibodies: a retrospective study in outpatients undergoing hemodialysis on unfractionated heparin.

Authors:  Satish Maharaj; Simone Chang; Karan Seegobin; James Morales; Agnes Aysola; Fauzia Rana; Marwan Shaikh
Journal:  Exp Hematol Oncol       Date:  2018-09-14

10.  To clot or not to clot? Ad is the question-Insights on mechanisms related to vaccine-induced thrombotic thrombocytopenia.

Authors:  Maha Othman; Alexander T Baker; Elena Gupalo; Abdelrahman Elsebaie; Carly M Bliss; Matthew T Rondina; David Lillicrap; Alan L Parker
Journal:  J Thromb Haemost       Date:  2021-08-23       Impact factor: 16.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.